Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 324.50 million as of December 20, 2024. Its market cap has decreased by -60.54% in one year.

Market Cap

324.50M

Enterprise Value

191.65M

Revenue

27.07M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.51

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 324.50M, a decrease of -80.56%. That is a compound annual growth rate of -18.88%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	324.50M	-55.22%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	7.03B	21.37%
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca PLC	2,202.72B
Swedish Orphan Biovitrum AB (publ)	106.60B
Sectra AB (publ)	52.64B
Getinge AB (publ)	47.41B
Camurus AB (publ)	33.14B
Medicover AB (publ)	28.89B
Vitrolife AB (publ)	28.16B
Bonesupport Holding AB (publ)	25.14B

Market Cap Rankings